Wider Approval for Cystic Fibrosis 'Miracle' Drug
The MHRA extended the licence for Kaftrio, a disease-modulating therapy for cystic fibrosis, to children under 12.
Source: medscape.com
Stay updated with breaking news from Changing Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The MHRA extended the licence for Kaftrio, a disease-modulating therapy for cystic fibrosis, to children under 12.